Kwality Pharmaceuticals Ltd. benchmarking: Perfomance to industry peers

Financial

	Kwality Pharma	Wanbury	Anuh Pharma
Operational Metrics
Financials
5 yr Average ROE	25.27 %	-11.27 %	15.87 %
5yr average Equity Multiplier	1.96	-1.35	1.62
5yr Average Asset Turnover Ratio	1.05	1.54	1.35
5yr Avg Net Profit Margin	11.66 %	5.09 %	7.23 %
Price to Book	3.53	15.71	2.7
P/E	21.47	21.65	19.04
5yr Avg Cash Conversion Cycle	55.02 Days	-103.0 Days	42.81 Days
Inventory Days	67.04 Days	21.96 Days	50.87 Days
Days Receivable	132.46 Days	61.39 Days	111.12 Days
Days Payable	126.93 Days	194.51 Days	117.6 Days
5yr Average Interest Coverage Ratio	16.13	2.13	48.66
5yr Avg ROCE	34.73 %	-37.9 %	21.17 %
5yr Avg Operating Profit Margin	23.23 %	7.72 %	10.21 %
5 yr average Debt to Equity	0.46	0.2	0.02
5yr CAGR Net Profit	21.34 %	n/a	10.73 %
5yr Average Return on Assets	12.96 %	7.92 %	9.84 %
Shareholdings
Promoter Holding	54.83 %	39.63 %	71.82 %
Share Pledged by Promoters	0.0	76.74 %	0.0
Change in Promoter Holding (3 Yrs)	0.38 %	-0.22 %	1.23 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

	Kwality Pharma	Wanbury	Anuh Pharma
Segment Break-Up	Segment Break-Up Formulations 100.0 Pharmaceuticals 0	Segment Break-Up Formulations 0 Pharmaceuticals 100.0	-
Formulations Breakup	Formulations Breakup Others 100	-	-
Location Wise Break-Up	Location Wise Break-Up India 47.21 Rest of the World 0 Others 52.79	Location Wise Break-Up Rest of the World 0 India 30.27 Others 69.73	Location Wise Break-Up Rest of the World 0 India 45.02 Others 54.98